GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimian Group AB (OTCPK:VIMGF) » Definitions » Gross Margin %

VIMGF (Vimian Group AB) Gross Margin % : 66.44% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Vimian Group AB Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Vimian Group AB's Gross Profit for the three months ended in Dec. 2024 was $73.0 Mil. Vimian Group AB's Revenue for the three months ended in Dec. 2024 was $109.8 Mil. Therefore, Vimian Group AB's Gross Margin % for the quarter that ended in Dec. 2024 was 66.44%.


The historical rank and industry rank for Vimian Group AB's Gross Margin % or its related term are showing as below:

VIMGF' s Gross Margin % Range Over the Past 10 Years
Min: 56.76   Med: 68.92   Max: 70.87
Current: 68.91


During the past 8 years, the highest Gross Margin % of Vimian Group AB was 70.87%. The lowest was 56.76%. And the median was 68.92%.

VIMGF's Gross Margin % is ranked better than
76.47% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: 47.925 vs VIMGF: 68.91

Vimian Group AB had a gross margin of 66.44% for the quarter that ended in Dec. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Vimian Group AB was 1.70% per year.


Vimian Group AB Gross Margin % Historical Data

The historical data trend for Vimian Group AB's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimian Group AB Gross Margin % Chart

Vimian Group AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Margin %
Get a 7-Day Free Trial 65.27 70.87 68.96 69.16 68.92

Vimian Group AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.42 69.27 70.52 69.85 66.44

Competitive Comparison of Vimian Group AB's Gross Margin %

For the Diagnostics & Research subindustry, Vimian Group AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimian Group AB's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vimian Group AB's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Vimian Group AB's Gross Margin % falls into.


;
;

Vimian Group AB Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Vimian Group AB's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as

Gross Margin % (A: Dec. 2024 )=Gross Profit (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=270.5 / 392.461
=(Revenue - Cost of Goods Sold) / Revenue
=(392.461 - 121.99) / 392.461
=68.92 %

Vimian Group AB's Gross Margin for the quarter that ended in Dec. 2024 is calculated as


Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=73 / 109.843
=(Revenue - Cost of Goods Sold) / Revenue
=(109.843 - 36.859) / 109.843
=66.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Vimian Group AB  (OTCPK:VIMGF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Vimian Group AB had a gross margin of 66.44% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Vimian Group AB Gross Margin % Related Terms

Thank you for viewing the detailed overview of Vimian Group AB's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vimian Group AB Business Description

Traded in Other Exchanges
Address
Riddargatan 19, Stockholm, SWE, SE-11457
Vimian Group AB specializes in the areas of animal health such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription and non-prescription treatments for preventive care, and treatment of chronic conditions for companion animals, with a strong position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.